The Filing Desk

Inogen vs InMode

Inogen INGN · InMode INMD · Health Care Equipment

InMode reported revenue of $370 million in fiscal 2025, about the same as Inogen's $349 million in fiscal 2025. Inogen's revenue grew 3.9% in its latest year, and InMode's fell 6.2%. Inogen had an operating margin of -8.7%, against 23.1% at InMode. Free cash flow was −$14 million at Inogen and $84 million at InMode.

Side by side

InogenInMode
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$349M$370M
Revenue growth3.9%−6.2%
Revenue growth a year, last 5 years2.5%12.4%
Gross margin44.2%78.5%
Operating margin−8.7%23.1%
Net margin−6.5%25.3%
Free cash flow−$14M$84M
Free cash flow margin−3.9%22.8%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$127M
Change in diluted share count12.5%−18.8%
Last close$5.42$12.70
P/E at the last close——
Insider trades, last 12 monthssold $142,519—
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
InogenInMode
Operating margin
Percent of revenue
InogenInMode
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
InogenInMode

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Inogen and InMode pages.